RT Journal Article
SR Electronic
T1 729 A first-in-human, open-label, multicenter, phase 1/2a, dose escalation and expansion study of GI-102, a novel immunocytokine combining CD80-IL2v3, in patients with advanced or metastatic solid tumors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A824
OP A824
DO 10.1136/jitc-2023-SITC2023.0729
VO 11
IS Suppl 1
A1 Lee, Jeeyun
A1 Cho, Byoung Chul
A1 Lee, Jae Lyun
A1 Lee, Jung-Yun
A1 Campian, Jian L
A1 Zhao, Yujie
A1 Seetharam, Mahesh
A1 Adjei, Alex A
A1 Ma, Wen Wee
A1 Chae, Dongwoo
A1 Yun, Nari
A1 Lee, Woosun
A1 Lee, Wooyul
A1 Park, Sosun
A1 Seo, Bochan
A1 Lee, Kyungwha
A1 Park, Chong Woo
A1 Jang, Myoung Ho
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A824.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.